Results
|
|
6041.
|
|
|
|
6042.
|
|
|
|
6043.
|
|
|
|
6044.
|
|
|
|
6045.
|
|
|
|
6046.
|
|
|
|
6047.
|
|
|
|
6048.
|
|
|
|
6049.
|
|
|
|
6050.
|
|
|
|
6051.
|
|
|
|
6052.
|
|
|
|
6053.
|
|
|
|
6054.
|
|
|
|
6055.
|
|
|
|
6056.
|
|
|
|
6057.
|
|
|
|
6058.
|
|
|
|
6059.
|
|
|
|
6060.
|
Effect of co-medications on paritaprevir, ritonavir, ombitasvir, dasabuvir and ribavirin pharmacokinetics: analysis of data from seven Phase II/III trials. [electronic resource] by
- Polepally, Akshanth R
- Badri, Prajakta S
- Parikh, Apurvasena
- Rodrigues, Lino
- Da Silva-Tillmann, Barbara A
- Mensing, Sven
- Podsadecki, Thomas J
- Awni, Walid M
- Dutta, Sandeep
- Menon, Rajeev M
Producer: 20180213
In:
Antiviral therapy vol. 21
Availability: No items available.
|